Context Impaired sensitivity to thyroid hormones has been demonstrated to be positively
associated with the prevalence of metabolic disorders. However, the relationship between …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease
globally, and its prevalence is rapidly increasing. Nonalcoholic steatohepatitis (NASH), a …

Background: Non-Alcoholic Fatty Liver Disease (NAFLD) is one the most prevalent causes
of chronic liver disease worldwide. In the absence of an approved drug treatment, lifestyle …

Background & Aims Physical activity (PA) is recommended in the management of non-
alcoholic fatty liver disease (NAFLD) given its beneficial effects on liver fat and …

The newly proposed term “metabolic dysfunction-associated fatty liver disease”(MAFLD) is
replacing the old term “non-alcoholic fatty liver disease”(NAFLD) in many global regions …

Extracellular vesicles (EVs) possess favorable biocompatibility and immunological
characteristics, making them optimal carriers for bioactive substances. In this study, an …

Abstract Background This Obesity Medicine Association (OMA) Clinical Practice Statement
(CPS) provides clinicians an overview of nonalcoholic fatty liver disease (NAFLD), potential …

Background: Non-alcoholic fatty liver disease (NAFLD) is a common concomitant condition
in patients with inflammatory bowel disease (IBD). We aim to assess the magnitude of this …

Background and aims Nonalcoholic fatty liver disease (NAFLD) now known as metabolic
dysfunction associated steatotic liver disease (MASLD) is closely associated with type 2 …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of abnormal liver
function tests worldwide, with an estimated prevalence ranging between 19–46% in the …